Home » Topics » Regulatory » NMPA

NMPA
RSS

China becomes first country to approve roxadustat

Dec. 18, 2018

China SFDA clears phase I trial of A-319 in B-cell malignancies

Nov. 13, 2018

Elunate approved in China for colorectal cancer

Sep. 5, 2018

CFDA approves INDs for Innovent's IBI-101 and IBI-307

July 27, 2018

Luye cleared for phase I trials in China with LY-03012

June 21, 2018

CFDA grants priority review to Pharnext's PXT-3003 for CMT1A

June 14, 2018

Ganovo approved in China for hepatitis C

June 13, 2018

CFDA clears HG-146 to enter clinical trials for multiple myeloma

May 11, 2018

CFDA approves IND for Suzhou Alphamab's HER2 bispecific antibody KN-026

April 16, 2018

Chinese authorities approve clinical trials of ZKAB-001

Jan. 30, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 2, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 2, 2025.
CMS vows to put more emphasis on MA plans’ prior authorization
BioWorld MedTech
Physicians aren’t the only ones who see prior authorization (PA) practices as a significant problem, but John Brooks, deputy administrator at CMS, told a med tech...
Filling the NIH funding gap to protect biopharma research
BioWorld
The Trump administration’s broad slash to university research budgets raises pertinent questions over impacts to the biopharma ecosystem, specifically how a...
100 days of uncertainty
BioWorld
The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...